Who Is Bill Gates?
Part One: How Bill Gates Monopolized Global Health
Part Two: Bill Gates’ Plan to Vaccinate the World
Part One: How Bill Gates Monopolized Global Health
BILL GATES: Hello. I’m Bill Gates, chairman of Microsoft. In this video you’re going to see the future.
Who is Bill Gates? A software developer? A businessman? A philanthropist? A global health expert?
This question, once merely academic, is becoming a very real question for those who are beginning to realize that Gates’ unimaginable wealth has been used to gain control over every corner of the fields of public health, medical research and vaccine development. And now that we are presented with the very problem that Gates has been talking about for years, we will soon find that this software developer with no medical training is going to leverage that wealth into control over the fates of billions of people.
GATES: [. . .] because until we get almost everybody vaccinated globally, we still won’t be fully back to normal.
Bill Gates is no public health expert. He is not a doctor, an epidemiologist or an infectious disease researcher. Yet somehow he has become a central figure in the lives of billions of people, presuming to dictate the medical actions that will be required for the world to go “back to normal.” The transformation of Bill Gates from computer kingpin to global health czar is as remarkable as it is instructive, and it tells us a great deal about where we are heading as the world plunges into a crisis the likes of which we have not seen before.
This is the story of How Bill Gates Monopolized Global Health.
You’re tuned in to The Corbett Report.
Until his reinvention as a philanthropist in the past decade, this is what many people thought of when they thought of Bill Gates:
NARRATOR: In the case of the United States vs Microsoft, the US Justice Department contended that the software giant had breached antitrust laws by competing unfairly against Netscape Communications in the internet browser market, effectively creating a monopoly. Bill’s first concern was that the prosecution could potentially block the release of his company’s latest operating system, Windows 98.
GATES: Are you asking me about when I wrote this e-mail or what are you asking me about?
DAVID BOIES: I’m asking you about January of ’96.
GATES: That month?
BOIES: Yes, sir.
GATES: And what about it?
BOIES: What non-Microsoft browsers were you concerned about in January of 96?
GATES: I don’t know what you mean: “concerned.”
BOIES: What is it about the word “concerned” that you don’t understand?
GATES: I’m not sure what you mean by it.
SOURCE: Bill Gates Deposition
STEVE JOBS: We’re going to be working together on Microsoft Office, on Internet Explorer, on Java, and I think that it’s going to lead to a very healthy relationship. So it’s a package announcement today. We’re very, very happy about it, we’re very, very excited about it. And I happen to have a special guest with me today via satellite downlink, and if we could get him up on the stage right now.
[BILL GATES APPEARS, CROWD BOOS]
DAN RATHER: Police and security guards in Belgium were caught flat-footed today by a cowardly sneak attack on one of the world’s wealthiest men. The target was Microsoft chairman Bill Gates, arriving for a meeting with community leaders. Watch what happens when a team of hit men meet him first with a pie in the face.
[GATES HIT IN THE FACE WITH PIE]
RATHER: Gates was momentarily and understandably shaken, but he was not injured. The hit squad piled on with two more pies before one of them was wrestled to the ground and arrested; the others—at least for the moment—got away. Gates went inside, wiped his face clean, and made no comment. He then went ahead with his scheduled meeting. No word on the motive for this attack.
SOURCE: Bill Gates Pie in Face
But, once reviled for the massive wealth and the monopolistic power that his virus-laden software afforded him, Gates is now hailed as a visionary who is leveraging that wealth and power for the greater good of humanity.
KLAUS SCHWAB: If in the 22nd century a book will be written about the entrepreneur of the 21st century [. . .] I’m sure that the person who will foremost come to the mind of those historians is certainly Bill Gates. [applause]
ANDREW ROSS SORKIN: I don’t think it’s hyperbole to say that Bill Gates is singularly—I would argue—the most consequential individual of our generation. I mean that.
ELLEN DEGENERES: Our next guest is one of the richest and most generous men in the world. Please welcome Bill Gates.
JUDY WOODRUFF: At a time when everyone is looking to understand the scope of the pandemic and how to minimize the threat, one of the best informed voices is that of businessman and philanthropist Bill Gates.
The process by which this reinvention of Gates’ public image took place is not mysterious. It’s the same process by which every billionaire has revived their public image since John D. Rockefeller hired Ivy Ledbetter Lee to transform him from the head of the Standard Oil hydrainto the kind old man handing out dimes to strangers.
MAN OFF CAMERA: Don’t you give dimes, Mr. Rockefeller? Please, go ahead.
WOMAN: Thank you, sir.
MAN: Thank you very much.
ROCKEFELLER: Thank you for the ride!
MAN: I consider myself more than amply paid.
ROCKEFELLER: Bless you! Bless you! Bless you!
More to the point, John D. Rockefeller knew that to gain the adoration of the public, he had to appear to give them what they want: money. He devoted hundreds of millions of dollars of his vast oil monopoly fortune to establishing institutions that, he claimed, were for the public good. The General Education Board. The Rockefeller Institute of Medical Research. The Rockefeller Foundation.
Similarly, Bill Gates has spent much of the past two decades transforming himself from software magnate into a benefactor of humanity through his own Bill & Melinda Gates Foundation. In fact, Gates has surpassed Rockefeller’s legacy with the Bill & Melinda Gates Foundation long having eclipsed The Rockefeller Foundation as the largest private foundation in the world, with $46.8 billion of assets on its books that it wields in its stated program areas of global health and development, global growth, and global policy advocacy.
And, like Rockefeller, Gates’ transformation has been helped along by a well-funded public relations campaign. Gone are the theatrical tricks of the PR pioneers—the ubiquitous ice cream cones of Gates’ mentor Warren Buffett are the last remaining holdout of the old Rockefeller-handing-out-dimes gimmick. No, Gates has guided his public image into that of a modern-day saint through an even simpler tactic: buying good publicity.
The Bill & Melinda Gates Foundation spends tens of millions of dollars per year on media partnerships, sponsoring coverage of its program areas across the board. Gates funds The Guardian‘s Global Development website. Gates funds NPR’s global health coverage. Gates funds the Our World in Data website that is tracking the latest statistics and research on the coronavirus pandemic. Gates funds BBC coverage of global health and development issues, both through its BBC Media Action organization and the BBC itself. Gates funds world health coverage on ABC News.
When the NewsHour with Jim Lehrer was given a $3.5 million Gates foundation grant to set up a special unit to report on global health issues, NewsHour communications chief Rob Flynn was asked about the potential conflict of interest that such a unit would have in reporting on issues that the Gates Foundation is itself involved in. “In some regards I guess you might say that there are not a heck of a lot of things you could touch in global health these days that would not have some kind of Gates tentacle,” Flynn responded.
Indeed, it would be almost impossible to find any area of global health that has been left untouched by the tentacles of the Bill & Melinda Gates Foundation.
It was Gates who sponsored the meeting that led to the creation of Gavi, the Vaccine Alliance, a global public-private partnership bringing together state sponsors and big pharmaceutical companies, whose specific goals include the creation of “healthy markets for vaccines and other immunisation products.” As a founding partner of the alliance, the Gates Foundation provided $750 million in seed funding and has gone on to make over $4.1 billion in commitments to the group.
Gates provided the seed money that created the Global Fund to Fight AIDS, Tuberculosis and Malaria, a public-private partnership that acts as a finance vehicle for governmental AIDS, TB, and malaria programs.
When a public-private partnership of governments, world health bodies and 13 leading pharmaceutical companies came together in 2012 “to accelerate progress toward eliminating or controlling 10 neglected tropical diseases,” there was the Gates Foundation with $363 million of support.
When the Global Financing Facility for Women, Children and Adolescents was launched in 2015 to leverage billions of dollars in public and private financing for global health and development programs, there was the Bill & Melinda Gates Foundation as a founding partner with a $275 million contribution.
When the Coalition for Epidemic Preparedness Innovations was launched at the World Economic Forum in Davos in 2017 to develop vaccines against emerging infectious diseases, there was the Gates Foundation with an initial injection of $100 million.
The examples go on and on. The Bill & Melinda Gates Foundation’s fingerprints can be seen on every major global health initiative of the past two decades. And beyond the flashy, billion-dollar global partnerships, the Foundation is behind hundreds of smaller country and region-specific grants—$10 million to combat a locust infestation in East Africa, or $300 million to support agricultural research in Africa and Asia—that add up to billions of dollars in commitments.
It comes as no surprise, then, that—far beyond the $250 million that the Gates Foundation has pledged to the “fight” against coronavirus—every aspect of the current coronavirus pandemic involves organizations, groups and individuals with direct ties to Gates funding.
From the start, the World Health Organization has directed the global response to the current pandemic. From its initial monitoring of the outbreak in Wuhan and its declaration in January that there was no evidence of human-to-human transmission to its live media briefings and its technical guidance on country-level planning and other matters, the WHO has been the body setting the guidelines and recommendations shaping the global response to this outbreak.
But even the World Health Organization itself is largely reliant on funds from the Bill & Melinda Gates Foundation. The WHO’s most recent donor report shows that the Bill & Melinda Gates Foundation is the organization’s second-largest donor behind the United States government. The Gates Foundation single-handedly contributes more to the world health body than Australia, Canada, France, Germany, Russia and the UK combined.
What’s more, current World Health Organization Director-General Tedros Adhanom Ghebreyesus is, in fact, like Bill Gates himself, not a medical doctor at all, but the controversial ex-Minister of Health of Ethiopia, who was accused of covering up three cholera outbreaks in the country during his tenure. Before joining the WHO, he served as chair of the Gates-founded Global Fund to Fight AIDS, Tuberculosis and Malaria, and sat on the board of the Gates-founded Gavi, the Vaccine Alliance, and the Gates-funded Stop TB Partnership.
The current round of lockdowns and restrictive stay-home orders in western countries was enacted on the back of alarming models predicting millions of deaths in the United States and hundreds of thousands in the UK.
HAYLEY MINOGUE: Imperial College in London released a COVID-19 report and that’s where most of our US leaders are getting the information they’re basing their decision making on.
[. . .]
The report runs us through a few different ways this could turn out depending on what our responses are. If we don’t do anything to control this virus, over 80% of people in the US would be infected over the course of the epidemic, with 2.2 million deaths from COVID-19.
BORIS JOHNSON: From this evening I must give the British people a very simple instruction: you must stay at home.
JUSTIN TRUDEAU: Enough is enough. Go home and stay home.
GAVIN NEWSOM: . . . a statewide order for people to stay at home
The work of two research groups was crucial in shaping the decision of the UK and US governments to implement wide-ranging lockdowns, and, in turn, governments around the world. The first group, the Imperial College COVID-19 Research Team, issued a report on March 16th that predicted up to 500,000 deaths in the UK and 2.2 million deaths in the US unless strict government measures were put in place.
The second group, the Institute for Health Metrics and Evaluation in Bill Gates’ home state of Washington, helped provide data that corroborated the White House’s initial estimates of the virus’ effects, estimates that have been repeatedly downgraded as the situation has progressed.
Unsurprisingly, the Gates Foundation has injected substantial sums of money into both groups. This year alone, the Gates Foundation has already given $79 million to Imperial College, and in 2017 the Foundation announced a $279 million investment into the IHME to expand its work collecting health data and creating models.
Anthony Fauci, meanwhile, has become the face of the US government’s coronavirus response, echoing Bill Gates’ assertion that the country will not “get back to normal” until “a good vaccine” can be found to insure the public’s safety.
ANTHONY FAUCI: If you want to get to pre-coronavirus . . . You know, that might not ever happen, in the sense of the fact that the threat is there. But I believe with the therapies that will be coming online and with the fact that I feel confident that over a period of time we will get a good vaccine, that we will never have to get back to where we are right back now.
Beyond just their frequent collaborations and cooperation in the past, Fauci has direct ties to Gates’ projects and funding. In 2010, he was appointed to the Leadership Council of the Gates-founded “Decade of Vaccines” project to implement a Global Vaccine Action Plan—a project to which Gates committed $10 billion of funding. And in October of last year, just as the current pandemic was beginning, the Gates Foundation announced a $100 million contribution to the National Institute of Health to help, among other programs, Fauci’s National Institute of Allergy and Infectious Diseases’ research into HIV.
Also in October of last year, the Bill & Melinda Gates Foundation partnered with the World Economic Forum and the Johns Hopkins Center for Health Security to stage Event 201, a tabletop exercise gauging the economic and societal impact of a globally-spreading coronavirus pandemic.
NARRATOR: It began in healthy-looking pigs months, perhaps years, ago: a new coronavirus.
ANITA CICERO: The mission of the pandemic emergency board is to provide recommendations to deal with the major global challenges arising in response to an unfolding pandemic. The board is comprised of highly experienced leaders from business public health and civil society.
TOM INGLESBY: We’re at the start of what’s looking like it will be a severe pandemic and there are problems emerging that can only be solved by global business and governments working together.
STEPHEN REDD: Governments need to be willing to do things that are out of their historical perspective, or . . . for the most part. It’s really a war footing that we need to be on.
Given the incredible reach that the tentacles of the Bill & Melinda Gates Foundation have into every corner of the global health markets, it should not be surprising that the foundation has been intimately involved with every stage of the current pandemic crisis, either. In effect, Gates has merely used the wealth from his domination of the software market to leverage himself into a similar position in the world of global health.
The whole process has been cloaked in the mantle of selfless philanthropy, but the foundation is not structured as a charitable endeavour. Instead, it maintains a dual structure: the Bill & Melinda Gates Foundation distributes money to grantees, but a separate entity, the Bill & Melinda Gates Foundation Trust, manages the endowment assets. These two entities often have overlapping interests, and, as has been noted many times in the past, grants given by the foundation often directly benefit the value of the trust’s assets:
MELINDA GATES: One of my favorite parts of my job at the Gates Foundation is that I get to travel to the developing world, and I do that quite regularly.
[. . .]
My first trip in India, I was in a person’s home where they had dirt floors, no running water, no electricity, and that’s really what I see all over the world. So in short, I’m startled by all the things that they don’t have. But I am surprised by one thing that they do have: Coca-Cola. Coke is everywhere. In fact, when I travel to the developing world, Coke feels ubiquitous.
And so when I come back from these trips, and I’m thinking about development, and I’m flying home and I’m thinking, we’re trying to deliver condoms to people, or vaccinations, you know? Coke’s success kind of stops and makes you wonder: How is it that they can get Coke to these far-flung places? If they can do that, why can’t governments and NGOs do the same thing?
AMY GOODMAN: And the charity of billionaire Microsoft founder Bill Gates and his wife Melinda is under criticism following the disclosure it’s substantially increased its holdings in the agribusiness giant Monsanto to over $23 million. Critics say the investment in Monsanto contradicts the Bill and Melinda Gates Foundation’s stated commitment to helping farmers and sustainable development in Africa.
LAURENCE LEE: The study from the pressure group Global Justice now paints a picture of the Gates Foundation partly as an expression of corporate America’s desire to profit from Africa and partly a damning critique of its effects.
POLLY JONES: You could have a case where the initial research is done by a Gates-funded institution. And the media reporting on how well that research is conducted is done, the media outlet is a Gates-funded outlet, or maybe a Gates-funded journalist from a media program. And then the program is implemented more widely by a Gates-funded NGO. I mean . . . There are some very insular circles here.
LEE: Among the many criticisms: the idea that private finance can solve the problems of the developing world. Should poor farmers be trapped into debt by having to use chemicals or fertilizers underwritten by offshoot of the foundation?
This is no mere theoretical conflict of interest. Gates is held up as a hero for donating $35.8 billion worth of his Microsoft stock to the foundation, but during the course of his “Decade of Vaccines,” Gates’ net worth has actually doubled, from $54 billion to $103.1 billion.
The Rockefeller story provides an instructive template for this vision of tycoon-turned-philanthropist. When Rockefeller faced a public backlash, he helped spearhead the creation of a system of private foundations that connected in with his business interests. Leveraging his unprecedented oil monopoly fortune into unprecedented control over wide swaths of public life, Rockefeller was able to kill two birds with one stone: molding society in his family’s own interests, even as he became a beloved figure in the public imagination.
Similarly, Bill Gates has leveraged his software empire into a global health, development and education empire, steering the course of investment and research and ensuring healthy markets for vaccines and other immunization products. And, like Rockefeller, Gates has been transformed from the feared and reviled head of a formidable hydra into a kindly old man generously giving his wealth back to the public.
But not everyone has been taken in by this PR trick. Even The Lancet observed this worrying transformation from software monopolist to health monopolist back in 2009, when the extent of this Gates-led monopoly was becoming apparent to all:
The first guiding principle of the [Bill & Melinda Gates] Foundation is that it is “driven by the interests and passions of the Gates family.” An annual letter from Bill Gates summarises those passions, referring to newspaper articles, books, and chance events that have shaped the Foundation’s strategy. For such a large and influential investor in global health, is such a whimsical governance principle good enough?
This brings us back to the question: Who is Bill Gates? What are his driving interests? What motivates his decisions?
These are not academic questions. Gates’ decisions have controlled the flows of billions of dollars, formed international partnerships pursuing wide-ranging agendas, ensured the creation of “healthy markets” for Big Pharma vaccine manufacturers. And now, as we are seeing, his decisions are shaping the entire global response to the coronavirus pandemic.
Next week, we will further explore Gates’ vaccination initiatives, the business interests behind them, and the larger agenda that is beginning to take shape as we enter the “new normal” of the COVID-19 crisis.
Part Two: Bill Gates’ Plan to Vaccinate the World
POPPY HARLOW: Ten billion dollars. I mean, just speak about the magnitude of that. That is by far the biggest commitment of the foundation, isn’t it, Bill? I mean this is by far the largest.
BILL GATES: That’s right, we’ve been spending a lot on vaccines. With this commitment, over eight million additional lives will be saved. So it’s one of the most effective ways that health in the poorest countries can be dramatically improved.
In January of 2010, Bill and Melinda Gates used the World Economic Forum at Davos to announce a staggering $10 billion commitment to research and develop vaccines for the world’s poorest countries, kicking off what he called a “decade of vaccines.”
GATES: Today we’re announcing a commitment over this next decade, which we think of as a decade of vaccines having incredible impact. We’re announcing that we’ll spend over $10 billion on vaccines.
Hailed by the Gates-funded media . . .
HARI SREENIVASAN: For the record, the Bill and Melinda Gates Foundation is a NewsHour underwriter.
. . . and applauded by the pharmaceutical companies who stood to reap the benefits of that largesse, the record-setting commitment made waves in the international community, helping to underwrite a Global Vaccine Action Plan coordinated by the Gates-funded World Health Organization.
But contrary to Gates’ own PR spin that this $10 billion pledge was an unalloyed good and would save 8 million lives, the truth is that this attempt to reorient the global health economy was part of a much bigger agenda. An agenda that would ultimately lead to greater profits for big pharma companies, greater control for the Gates Foundation over the field of global health, and greater power for Bill Gates to shape the course of the future for billions of people around the planet.
This is Bill Gates’ Plan to Vaccinate the World.
You’re tuned into The Corbett Report.
Given Gates’ pledge to make this a “Decade of Vaccines,” it should come as no surprise that, since the dawn of this coronavirus crisis, he has been adamant that the world will not go back to normal until a vaccine has been developed.
GATES: We’re gonna have this intermediate period of opening up, and it won’t be normal until we get an amazing vaccine to the entire world.
GATES: The vaccine is critical, because, until you have that, things aren’t really going to be normal. They can open up to some degree, but the risk of a rebound will be there until we have very broad vaccination.
GATES: They won’t be back to normal until we either have that phenomenal vaccine or a therapeutic that’s like over 95% effective. And so we have to assume that’s going to be almost 18 months from now.
GATES: And then the final solution—which is a year or two years off—is the vaccine.
COLBERT: Just to head off the conspiracy theorists, maybe we shouldn’t call the vaccine “the final solution.”
GATES: Good point.
COLBERT: Maybe just “the best solution.”
More interestingly, since Gates began delivering this same talking point in every one of his many media appearances of late, it has been picked up and repeated by heads of state, health officials, doctors and media talking heads, right down to the scientifically arbitrary but very specific 18-month time frame.
ZEKE EMANUEL: Realistically, COVID-19 will be here for the next 18 months or more. We will not be able to return to normalcy until we find a vaccine or effective medications.
DOUG FORD: The hard fact is, until we have a vaccine, going back to normal means putting lives at risk.
JUSTIN TRUDEAU: This will be the new normal until a vaccine is developed.
NORMAN SWAN: The only thing that will really allow life as we once knew it to resume is a vaccine.
DONALD TRUMP: Obviously, we continue to work on the vaccines, but the vaccines have to be down the road by probably 14, 15, 16 months. We’re doing great on the vaccines.
The fact that so many heads of state, health ministers and media commentators are dutifully echoing Gates’ pronouncement about the need for a vaccine will not be surprising to those who saw last week’s exploration of How Bill Gates Monopolized Global Health. As we have seen, the Gates Foundation’s tentacles have penetrated into every corner of the field of public health. Billions of dollars in funding and entire public policy agendas are under the control of this man, an unelected, unaccountable software developer with no medical research experience or training.
And nowhere is Gates’ control of global public health more apparent than in the realm of vaccines.
Gates launched the Decade of Vaccines with a $10 billion pledge.
Gates helped found Gavi, the Vaccine Alliance, aiming to develop “healthy markets” for vaccine manufacturers.
Gates helped launch Gavi with a $1 billion donation in 2011, going on to contribute $4.1 billionover the course of the Decade of Vaccines.
GATES: And so I’m pleased to announce to you that we’re pledging an additional billion dollars—
GATES: Thank you.
GATES: Alright, thank you. It’s not everyday we give away a billion dollars.
SOURCE: Gates’ mammoth vaccine pledge
One of the Gates Foundation’s core funding areas is “vaccine development and surveillance,” which has resulted in the channeling of billions of dollars into vaccine development, a seat at the table to develop vaccination campaigns in countries around the globe, and the opportunity to shape public thinking around Bill Gates’ pet project of the past five years: preparing rapid development and deployment of vaccines in the event of a globally-spreading pandemic.
GATES: If anything kills over 10 million people in the next few decades, it’s most likely to be a highly infectious virus.
GATES: Whether it occurs by a quirk of nature or at the hand of a terrorist, epidemiologists show through their models that a respiratory spread pathogen would kill more than 30 million people in less than a year and there is a reasonable probability of that taking place in the years ahead.
BABITA SHARMA: Many high-profile personalities have been meeting at this week’s World Economic Forum in Davos, which aims to discuss the globe’s most pressing issues. Amongst them is Microsoft founder Bill Gates, whose foundation is investing millions in the Coalition for Epidemic Preparedness Innovations to help combat infectious diseases. Here’s some of what he had to say about his push to develop new vaccines.
SOURCE: BBC Newsday January 19, 2017
GATES: Unfortunately, it takes many years to do a completely new vaccine. The design, the safety review, the manufacturing; all those things mean that an epidemic can be very widespread before that tool would come along. And so after ebola the global health community talked a lot about this, including a new type of vaccine platform called DNA/RNA that should speed things along.
And so this Coalition for Epidemic Preparedness Initiative [sic], CEPI, is three countries—Japan, Norway, Germany—and two foundations—Wellcome Trust, [who] we work with on a lot of things, and our foundation, the Gates Foundation—coming together to fund . . . actually trying to use that platform and make some vaccines. And so that would help us in the future.
NARRATORS: We know vaccines can protect us. We just need to be better prepared. So let’s come together, let’s research and invest. Let’s save lives. Let’s outsmart epidemics.
SOURCE: Let’s #OutsmartEpidemics
Given Gates’ mammoth investment in vaccines over the past decade, his insistence that . . .
GATES: Things won’t go back to truly normal until we have a vaccine that we’ve gotten out to basically the entire world.
. . . is hardly surprising.
What should be surprising is that this strangely specific and continuously repeated message—that we will not go “back to normal” until we get a vaccine in 18 months—has no scientific basis whatsoever. Medical researchers have already conceded that a vaccine for SARS-CoV-2 may not even be possible, pointing to the inability of researchers to develop any kind of immunization against previous coronavirus outbreaks, like SARS or MERS.
But even if such a vaccine were possible, serious concerns remain about the safety of developing, testing and delivering such an “amazing vaccine” to “the entire world” in this remarkably short timeframe. Even proponents of vaccine development openly worry that the rush to vaccinate billions of people with a largely untested, experimental coronavirus vaccine will itself present grave risks to the public.
One of these risks involves “disease enhancement.” It has been known for over a decade that vaccination for some viral infections—including coronaviruses—actually enhances susceptibility to viral infection or even causes infections in healthy vaccine recipients.
ANTHONY FAUCI: Now, the issue of safety. Something that I want to make sure the American public understand: It’s not only safety when you inject somebody and they get maybe an idiosyncratic reaction, they get a little allergic reaction, they get pain. There’s safety associated. “Does the vaccine make you worse?” And there are diseases in which you vaccinate someone, they get infected with what you’re trying to protect them with, and you actually enhance the infection.
This is no mere theoretical risk. As researchers who were trying to develop a vaccine for the original SARS outbreak discovered, the vaccine actually made the lab animals subjected to it more susceptible to the disease.
PETER HOTEZ: One of the things we are not hearing a lot about is potential safety problems of coronavirus vaccines. This was first found in the 1960s with Respiratory Syncytial Virus vaccines done in Washington with the NIH and Children’s National Medical Center. Some of those kids who got the vaccine actually did worse, and I believe there were two deaths as a consequence of that study. Because what happens with certain types of respiratory virus vaccines, you get immunized and then when you get actually exposed to the virus you get this kind of paradoxical immune enhancement phenomenon and what—and we we don’t entirely understand the basis of it. But we recognize that it’s a real problem for certain respiratory virus vaccines. That killed the RSV program for decades. Now the Gates Foundation is taking it up again. But when we started developing coronavirus vaccines—and our colleagues—we noticed in laboratory animals that they started to show some of the same immune pathology that resembled what had happened 50 years earlier.
This specific issue regarding coronavirus vaccines is exacerbated by the arbitrary and unscientific 18-month timeframe that Gates is inisisting on for the vaccine’s development. In order to meet that deadline, vaccine developers are being urged to use new and largely unproven methods for creating their experimental immunizations, including DNA and mRNA vaccines.
KELLY O’DONNELL: For a self-described wartime president victory over COVID-19 equals a vaccine.
TRUMP: I hope we can have a vaccine and we’re going to fast-track it like you’ve never seen before.
O’DONNELL: Adding Trump-style branding, the administration launched “Operation Warp Speed,” a multi-billion dollar research and manufacturing effort to shorten the typical year-plus vaccine development timeline.
ANTHONY FAUCI: We’re gonna start ramping up production with the companies involved, and you do that at risk. In other words, you don’t wait until you get an answer before you start manufacturing. You at risk proactively start making it, assuming it’s going to work.
BECKY QUICK: You’re thinking 18 months even with all the work that you’ve already done to this point and the planning that you are taking with lots of different potential vaccinations and building up for that now
GATES: Yeah, so the there’s an approach called RNA vaccine that people like Moderna, CureVac and others are using that in 2015 we identified that is very promising for pandemics and for other applications as well. And so if everything goes perfectly with the RNA approach we could actually beat the 18 months. We don’t want to create unrealistic expectations.
RHIJU DAS: So the concept of an RNA vaccine is: Let’s inject the RNA molecule that encodes for the spike protein.
ANGELA RASMUSSEN: It’s making your cell effectively do the work of creating this viral protein that is going to be recognized by your immune system and trigger the development of these antibodies.
DAS: Our bodies won’t make a full-fledged infectious virus. They’ll just make a little piece and then learn to recognize it and then get ready to destroy the virus if it then later comes and invades us.
[. . .]
DAS: It’s a relatively new, unproven technology. And there’s still no example of an RNA vaccine that’s been deployed worldwide in the way that we need for the coronavirus.
RASMUSSEN: There is the possibility for unforeseen, adverse effects.
AKIKO IWASAKI: So this is all new territory. Whether it would elicit protective, robust immune response against this virus is just unknown right now.
Rushing at “Warp Speed” to develop a new vaccine using experimental technology and then mass producing and delivering billions of doses to be injected into “basically the entire world” before adequate testing is even done amounts to one of the most dangerous experiments in the history of the world, one that could alter the lives of untold numbers of people.
That an experimental vaccine—developed in a brand new way and rushed through with a special, shortened testing regime—should be given to adults, children, pregnant women, newborn babies, and the elderly alike, would be, in any other situation, unthinkable. To suggest that such a vaccine should be given to the entire planet would have been called lunacy mere months ago. But now the public is being asked to accept this premise without question.
Even Gates himself acknowledges the inherent risks of such a project. But his concern is not for the lives that will be irrevocably altered in the event that the vaccines cause damage to the population. Instead, he is more concerned that the pharmaceutical companies and the researchers are given legal immunity for any such damage.
GATES: You know, if we have you know, one in 10,000 side effects, that’s, you know, way more, 700,000, you know, people who will suffer from that. So really understanding the safety at gigantic scale across all age ranges—you know, pregnant, male, female, undernourished, existing comorbidities—it’s very very hard. And that actual decision of, “OK, let’s go and give this vaccine to the entire world,” governments will have to be involved because there will be some risk and indemnification needed before that can be decided on.
As we have already seen, in the arena of global health, what Bill Gates wants is what the world gets. So it should be no surprise that immunity for the Big Pharma vaccine manufacturers and the vaccination program planners is already being worked on.
In the US, the Department of Health and Human Services issued a declaration that retroactively provides “liability immunity for activities related to medical countermeasures against COVID-19,” including manufacturers, distributors and program planners of “any vaccine, used to treat, diagnose, cure, prevent, or mitigate COVID-19.” The declaration was issued on March 17th but retroactively covers any activity back to February 4, 2020, the day before the Bill & Melinda Gates Foundation announced an emergency $100 million to fund treatment efforts and to develop new vaccines for COVID-19.
The plan to inject everyone on the planet with an experimental vaccine is no aberration in Bill Gates’ envisioned “Decade of Vaccines.” It is its culmination.
The Decade of Vaccines kicked off with a Gates-funded $3.6 million observational study of HPV vaccines in India that, according to a government investigation, violated the human rights of the study participants with “gross violations” of consent, and failed to properly report adverse events experienced by the vaccine recipients. After the deaths of seven girls involved in the trial were reported, a parliamentary investigation concluded that the Gates-funded Program for Appropriate Technology in Health (PATH), which ran the study, had been engaged in a scheme to help ensure “healthy markets” for GlaxoSmithKline and Merck, the manufacturers of the Gardasil and Cervarix vaccines that had been so generously donated for use in the trial:
“Had PATH been successful in getting the HPV vaccine included in the universal immunization program of the concerned countries, this would have generated windfall profit for the manufacturer(s) by way of automatic sale, year after year, without any promotional or marketing expenses. It is well known that once introduced into the immunization program it becomes politically impossible to stop any vaccination.”
Chandra M. Gulhati, editor of the influential Monthly Index of Medical Specialities, remarkedthat “It is shocking to see how an American organization used surreptitious methods to establish itself in India” and Samiran Nundy, editor emeritus of the National Medical Journal of Indialamented that “This is an obvious case where Indians were being used as guinea pigs.”
Throughout the decade, India’s concerns about the Bill & Melinda Gates Foundation and its corporate partners’ influence on the country’s national immunization programs grew. In 2016, the steering group of the country’s National Health Mission blasted the government for allowing the country’s National Technical Advisory Group on Immunisation—the primary body advising the government on all vaccination-related matters—to be effectively purchased by the Gates Foundation.
As one steering group member noted: “The NTAGI secretariat has been moved out of the [government’s health] ministry to the office of Public Health Foundation of India and the 32 staff members in that secretariat draw their salaries from the BMGF. There is a clear conflict of interest—on one hand, the BMGF funds the secretariat that is the highest decision making body in vaccines and, on the other, it partners the pharma industry in GAVI. This is unacceptable.”
In 2017, the government responded by cutting all financial ties between the advisory group and the Gates Foundation.
Similar stories play out across the Gates Foundation’s Decade of Vaccines.
There’s the Gates-founded and funded Meningitis Vaccine Project, which led to the creation and testing of MenAfriVac, a $0.50 per dose immunization against meningococcal meningitis. The tests led to reports of between 40 and 500 children suffering seizures and convulsions and eventually becoming paralyzed.
There’s the 2017 confirmation that the Gates-supported oral polio vaccine was actually responsible for the majority of new polio cases, and the 2018 follow up showing that 80% of polio cases are now vaccine-derived.
There’s the 2018 paper in the International Journal of Environmental Research and Public Healthconcluding that over 490,000 people in India developed paralysis as a result of the oral polio vaccine between 2000 and 2017.
There’s even the WHO’s own malaria chief, Dr. Arata Kochi, who complained in an internal memothat Gates’ influence meant that the world’s leading malaria scientists are now “locked up in a ‘cartel’ with their own research funding being linked to those of others within the group,” and that the foundation “was stifling debate on the best ways to treat and combat malaria, prioritizing only those methods that relied on new technology or developing new drugs.”
Kochi’s complaint, written in 2008, highlights the most common criticism of the global health web that Gates has spun in the past two decades: That the public health industry has become a racket run by and for Big Pharma and its partners for the benefit of big business.
At the time that Kochi was writing his memo, the executive director of the Gates Foundation’s Global Health program was Tachi Yamada. Yamada left his position as Chairman of Research and Development at GlaxoSmithKline to take up the position at the Gates Foundation in 2006, and left the foundation five years later to become Chief Medical and Scientific Officer at Takeda Pharmaceuticals. Yamada’s replacement as head of Gates’ Global health program, Trevor Mundelwas himself a clinical researcher at Pfizer and Parke-Davis and spent time as head of development with Novartis before joining the foundation.
This use of foundation funds to set public policy to drive up corporate profits is not a secret conspiracy. It is a perfectly open one.
When the Center for Global Development formed a working group to “develop a practical approach to the vaccine challenge,” they concluded that the best way to incentivize pharmaceutical companies to produce more vaccines for the third world was for governments to promise to buy vaccines before they were even developed. They titled their report “Making Markets for Vaccines.”
ALICE ALBRIGHT: The project “Making Markets for Vaccines” was really designed to address a problem that’s existed for a long time, which is insufficient research and development budgets as well as investment capacity in vaccine development and production for the third world. How do you create better incentives to get the pharma community—the vaccine community—to produce products that are specifically dedicated for the developing world.
RUTH LEVINE: Michael Kramer, a professor at Harvard, had been thinking about this problem for many years.
OWEN BARDER: He realized that if the rich countries of the world were to make a promise that they would buy a malaria vaccine if somebody produced it, that would give an incentive to the pharmaceutical industry to go and do the research and development needed to make one. But this idea was unfamiliar. No government had made a commitment to buy a product that didn’t already exist.
SOURCE: Making Markets for Vaccines
When the first such “Advanced Market Commitment” was made in 2007—a $1.5 billion promise to buy yet-to-be-produced vaccines from Big Pharma manufacturers—there was the Gates Foundation as the only non-nation sponsor.
The Gates-founded Gavi Vaccine Alliance is an open partnership between the Gates Foundation, the World Health Organization, the World Bank and the vaccine manufacturers. Their stated goals includes “introducing new vaccines into the routine schedules of national immunization programmes” and to engage in “market shaping efforts” to ensure “healthy markets for vaccines and other immunization products.”
If “introducing new vaccines” and ensuring healthy markets for them was the aim of Gates’ “Decade of Vaccines,” there can be no doubt that COVID-19 has seen that goal realized in spectacular fashion.
URSULA VON DER LEYEN: Let’s start the pledging.
KATIE STEPHENS: The EU kicked off its fundraising drive with 1 billion euros. In the hours that followed, pledges were beamed in from across the globe.
TAWFIG ALRABIAH: The Kingdom of Saudi Arabia has pledged 500 million dollars.
STEPHENS: Even pop icon Madonna made a last-minute donation of a million euros.
MELINDA GATES: By combining the world’s expertise and brainpower and resources, we can attack this disease in the way it’s attacking us: globally. Our foundation is proud to partner with you and I’m pleased to announce today that we will pledge a hundred million dollars towards this effort.
KATIE STEPHENS: Germany was one of the leading donors, pledging over five hundred million euros. The money is earmarked for international health organizations and research networks in a bid to speed up the development of a vaccine.
And there, at the center of this web, is the Gates Foundation, connected to every major organization, research institution, international alliance and vaccine manufacturer involved in the current crisis.
Certainly, the Gates—like the Rockefellers—have profited from their years as “the most generous people on the planet.” As curious as it might seem to those who don’t understand the true nature of this monopoly cartel, despite all of these grants and pledges—commitments of tens of billions of dollars—Bill Gates’ personal net worth has actually doubled during this Decade of Vaccines, from $50 billion to over $100 billion.
But once again we come back to the question: Who is Bill Gates? Is he motivated simply by money? Is this incessant drive to vaccinate the entire population of the planet merely the result of greed? Or is there something else driving this agenda?
As we shall see next time, money is not the end goal of Gates’ “philanthropic” activities. Money is just the tool that he is using to purchase what he really wants: control. Control not just of the health industry, but control of the human population itself.